Literature DB >> 1603880

Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.

D Marazziti1, E Hollander, P Lensi, S Ravagli, G B Cassano.   

Abstract

In an attempt to clarify the possible role of a serotonergic and dopaminergic dysfunction in obsessive-compulsive disorder (OCD), we measured platelet 3H-imipramine (3H-IMI) binding, serotonin uptake, and platelet sulfotransferase activity in 17 drug-free OCD patients and an equal number of healthy controls. Serotonin uptake and 3H-IMI binding sites in platelets have been shown to constitute peripheral markers of those present in presynaptic serotonergic neurons. Sulfotransferase, an enzyme involved in the catabolism of phenolic compounds and of cathecholamines such as dopamine, has similar kinetic characteristics in brain and platelets. Our results showed a lower number of 3H-IMI binding sites and a higher level of sulfotransferase activity in OCD patients compared with those in controls. These preliminary results suggest involvement of both the serotonin and dopamine systems in OCD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1603880     DOI: 10.1016/0165-1781(92)90037-4

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.

Authors:  Christopher Pittenger; Thomas G Adams; Jean-Dominique Gallezot; Michael J Crowley; Nabeel Nabulsi; Hong Gao; Stephen A Kichuk; Ryan Simpson; Eileen Billingslea; Jonas Hannestad; Michael Bloch; Linda Mayes; Zubin Bhagwagar; Richard E Carson
Journal:  J Affect Disord       Date:  2016-02-09       Impact factor: 4.839

Review 2.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

3.  Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.

Authors:  Richard Delorme; Catalina Betancur; Jacques Callebert; Nadia Chabane; Jean-Louis Laplanche; Marie-Christine Mouren-Simeoni; Jean-Marie Launay; Marion Leboyer
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

4.  Growth hormone response to apomorphine in obsessive-compulsive disorder.

Authors:  W Pitchot; M Hansenne; A G Moreno; M Ansseau
Journal:  J Psychiatry Neurosci       Date:  1996-11       Impact factor: 6.186

5.  The structure of the catechin-binding site of human sulfotransferase 1A1.

Authors:  Ian Cook; Ting Wang; Mark Girvin; Thomas S Leyh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-23       Impact factor: 11.205

6.  Platelet abnormalities in aggressive subjects with mental deficiency.

Authors:  D Marazziti; L Palego; S Silvestri; S Presta; C Balestri; A Batistini; L Conti
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

7.  Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.

Authors:  Dimitris Kontis; Vasileios Boulougouris; Vasiliki Maria Papakosta; Stamatina Kalogerakou; Socrates Papadopoulos; Cornelia Poulopoulou; George N Papadimitriou; Eleftheria Tsaltas
Journal:  Psychopharmacology (Berl)       Date:  2008-07-14       Impact factor: 4.530

Review 8.  Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.

Authors:  J L Jarry; F J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

9.  Monoamine activity reflected in urine of young patients with obsessive compulsive disorder, psychosis with and without reality distortion and healthy subjects: an explorative analysis.

Authors:  R D Oades; B Röpcke; C Eggers
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 10.  Pharmacotherapeutic Strategies and New Targets in OCD.

Authors:  Christopher Pittenger
Journal:  Curr Top Behav Neurosci       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.